These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8021012)

  • 1. Vascular hypertrophy in renal hypertensive spontaneously hypertensive rats.
    Dilley RJ; Kanellakis P; Oddie CJ; Bobik A
    Hypertension; 1994 Jul; 24(1):8-15. PubMed ID: 8021012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats.
    Owens GK; Schwartz SM; McCanna M
    Hypertension; 1988 Feb; 11(2):198-207. PubMed ID: 3343047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular growth responses in SHR and WKY during development of renal (1K1C) hypertension.
    Black MJ; Niklaus A; Bertram JF; Dilley R; Bobik A
    Am J Hypertens; 1997 Jan; 10(1):43-50. PubMed ID: 9008247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat.
    Owens GK
    Circ Res; 1985 Apr; 56(4):525-36. PubMed ID: 3978772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats.
    Shaw LM; Ohanian J; Heagerty AM
    Hypertension; 1997 Sep; 30(3 Pt 1):442-8. PubMed ID: 9314430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
    Li JS; Schiffrin EL
    Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of transforming growth factor-beta 1 responses and vascular smooth muscle growth in spontaneously hypertensive rats.
    Saltis J; Bobik A
    J Hypertens; 1995 Dec; 13(12 Pt 1):1441-8. PubMed ID: 8866906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
    Owens GK
    Hypertension; 1987 Feb; 9(2):178-87. PubMed ID: 3546119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of the arterial media in transplanted arteries of spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY).
    Pang SC; Scott TM
    Artery; 1985; 12(6):382-7. PubMed ID: 4051757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased velocity of shortening in arterial smooth muscle from older (28- to 31-week-old) spontaneously hypertensive rats.
    Packer CS; Kagan ML; Stephens NL
    Can J Physiol Pharmacol; 1986 Jan; 64(1):96-100. PubMed ID: 3955449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensated function in hypertrophied ventricles of Wistar Kyoto and spontaneously hypertensive rats.
    Tomanek RJ; Whitaker MT
    Cardiovasc Res; 1990 Mar; 24(3):204-9. PubMed ID: 2140712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
    Gillies LK; Lu M; Wang H; Lee RM
    Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced vascular neuropeptide Y-immunoreactive innervation in two hypertensive rat strains.
    Fan XM; Hendley ED; Forehand CJ
    Hypertension; 1995 Nov; 26(5):758-63. PubMed ID: 7591015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats.
    Baumbach GL; Hajdu MA
    Hypertension; 1993 Jun; 21(6 Pt 1):816-26. PubMed ID: 8500863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia.
    Nolan BP; Senechal P; Waqar S; Myers J; Standley CA; Standley PR
    Am J Hypertens; 2003 May; 16(5 Pt 1):393-400. PubMed ID: 12745202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function.
    Adams MA; Bobik A; Korner PI
    Hypertension; 1989 Aug; 14(2):191-202. PubMed ID: 2527201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased medial smooth muscle cell length is responsible for vascular hypertrophy in young hypertensive rats.
    Dickhout JG; Lee RM
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2085-94. PubMed ID: 11045941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats.
    Mulvany MJ; Korsgaard N
    J Hypertens; 1983 Oct; 1(3):235-44. PubMed ID: 6241623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.